RelayPro Thoracic Stent-Graft System 28-N4-34-209-34URecalls & reported problems
Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant
All models of RelayPro Thoracic Stent-Graft System (127)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00843576150737), received between Oct 16, 2024 and Nov 10, 2025 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Difficult or Delayed Separation” (2 reports).
2 FDA recall records name this device's identifier, 2 still open.
1 other recall cover devices cleared under the same FDA submission (P200045); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Apr 22, 2026Class IOpen, Classified
Labeling update concerning proximal clasp disconnection from the outer control tube which may prevent stent graft from being released from the delivery system.
Z-2160-2026 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
- Dec 20, 2022Class IIOpen, Classified
The product may be shorter than packaging indicates
Z-0998-2023 · Root cause: Labeling Change Control · Recall details · FDA record ↗
Most reported problems
Device problems
- Difficult or Delayed Separation2
- Activation, Positioning or Separation Problem1
- Device Endoleak1
- Ejection Problem1
- Retraction Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Clinical Endoleak1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 10, 2025Retraction Problem; Activation, Positioning or Separation Problem; Difficult or Delayed Separation; Retraction Problem; Activation, Positioning or Separation Problem; Difficult or Delayed Separation
"TEVAR OF DESCENDING THORACIC AORTA PROXIMAL ZONE 4 TO DISTAL ZONE 5/PROXIMAL ZONE 6. PATIENT HAS PREVIOUSLY PLACED GORE TEVAR IN DISTAL ZONE 4 TO MID-DISTAL ZONE 5. ACCESS GAINED WITH 8 FR AND PIGTAIL CATHETER TRACKED OVER GLIDEWIRE INTO AORTIC ARCH. ANGIOGRAM AND MARKING LANDMARKS ON SCREEN, LUNDERQUIST WIRE ADVANCED THROUGH CATHETER AND CATHETER REMOVED. RELAY PRO DEVICE PER IFU. 8 FR SHEATH REMOVED AND RELAY PRO DEVICE ATTACHED INTO POSITION. DELIVERY SYSTEM SWITCHED TO POSITION 2 AND INNER CURVED SHEATH ADVANCED WITHOUT ISSUE. ATTEMPTED TO RETRACT FABRIC SHEATH TO START UNCOVERING STENT GRAFT BY TURNING HANDLE COUNTERCLOCKWISE BUT NOTICED D MARKER NOT MOVING. SWITCHED BACK TO POSITION 1 AND ADVANCE THE SYSTEM SLIGHTLY, SWITCHED BACK TO POSITION 2 AND DEPRESSED BUTTON AND UNSHEATHED STENT WITHOUT ISSUE. TURNED POSITION 3 AND TRIED TO DISCONNECT STENT BUT WAS MEETING RESISTANCE. A LITTLE MORE EFFORT AND STENT WAS DETACHED. SWITCHED TO POSITION 4 AND NOSE CONE WAS RETRACTED INTO OUTER SHEATH. DEVICE REMOVED, 18 FR DRYSEAL INSERTED SO THAT FINAL RUN COULD BE DONE WHICH SHOWED GOOD SEAL PROXIMAL AND DISTAL AND EXCLUSIVE OF ANEURYSM. CLOSURE WITH TWO PERCLOSE DEVICES." PATIENT OUTCO
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23512849 ↗MalfunctionNov 6, 2024Ejection Problem; Difficult or Delayed Separation; Ejection Problem; Difficult or Delayed Separation
"DEFECTIVE: THE RELAY PRO STENT-GRAFT CONCERNED AND A RELAY PRO STENT-GRAFT (28-N4-30-104-30U, LOT#: 2401090104) WERE USED TO TREAT AORTIC DISSECTION. AFTER THE FIRST STENT-GRAFT (28-N4-30-104-30U, LOT#: 2401090104) WAS IMPLANTED WITHOUT ANY PROBLEM, THE SECOND STENT-GRAFT CONCERNED WAS DEPLOYED WITH THE CONTROLLER IN THE "2" POSITION WITHOUT ANY PROBLEM. HOWEVER, THE APEX HOLDER COULD NOT BE RELEASED FROM THE DELIVERY SYSTEM TIP EVEN THOUGH THE APEX HOLDER KNOB WAS PULLED IN THE "3" POSITION. ALTHOUGH THE APEX HOLDER KNOB WAS ABLE TO BE PULLED IN THE "3" POSITION AND TORQUE WAS TRANSMITTED TO THE APEX HOLDER, THE APEX HOLDER WAS PULLED ALONG WITH THE DELIVERY SYSTEM TIP DISTALLY AND WAS NOT RELEASE. (AT THAT TIME, AS BAIL-OUT TECHNIQUE, THE STAINLESS-STEEL ROD WAS PUSHED AND ROTATED IN THE "4" POSITION, AND THE APEX HOLDER KNOB WAS PULLED IN THE "3" POSITION WHILE THE STAINLESS-STEEL ROD WAS BEING PUSHED IN THE "4" POSITION. HOWEVER, THE APEX HOLDER DID NOT SEEM TO BE RELEASED.) CUT-DOWN TECHNIQUE WAS THEREFORE USED ON THE CONTRALATERAL SIDE (LEFT LEG) TO INSERT A DRY SEAL SHEATH (18FR, GORE). A BALLOON CATHETER WAS THEN ADVANCED THROUGH THE DRY SEAL SHEATH, AND THE BALLOON WAS IN
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20623642 ↗InjuryOct 16, 2024Device Endoleak; Device Endoleak
"ENDOLEAK (TYPE IIIA): STENT-GRAFT IMPLEMENTATION WAS PERFORMED TO TREAT A DESCENDING AORTIC ANEURYSM. A STENT-GRAFT (28-N4-34-209-34U) WAS FIRST IMPLEMENTED ON THE DISTAL SIDE AND THE STENT-GRAFT (28-M4-40-195-36U) WAS THEN IMPLEMENTED ON THE PROXIMAL SIDE. POST DILATATION WAS PERFORMED, AND THE PROCEDURE WAS SUCCESSFULLY COMPLETED. ONE WEEK AFTER THE PROCEDURE, HOWEVER, CONTRAST-ENHANCED CT REVEALED A TYPE IIIA ENDOLEAK. SINCE THE PATIENT IS OLD, THE PATIENT IS BEING FOLLOWED UP. IF THE ANEURYSM TENDS TO ENLARGE, ADDITIONAL TREATMENT WILL BE SCHEDULED. OPERATION TYPE: STENT GRAFT IMPLANTATION. BLOOD LOSS: UNKNOWN. ANCILLARY DEVICE USED: 28-N4-34-209-34U. NO IMAGE AVAILABLE DUE TO HOSPITAL POLICY. PRE-CASE PLAN AVAILABLE (SEE THE ATTACHED SCHEMA.) ADDITIONAL INFORMATION WILL BE ABLE TO BE OBTAINED. (TC#(B)(6))". PATIENT OUTCOME: "NO HEALTH DAMAGE TO THE PATIENT."
Patient problems: Clinical Endoleak
MAUDE report 20465573 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P200045. One submission often covers many models, so check the product and lot details in each record.
- Z-1383-2024 · Feb 22, 2024 · CompletedRELAY PRO Thoracic Stent-Graft System, containing one endovascular stent-graft system, IFU, and patient tracking card, sterile: (a) Part number 28-M4-34-100-34U; (b) Part number 2
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page